MacroGenics
MGNX
#8209
Rank
โ‚น27.18 B
Marketcap
โ‚น427.64
Share price
-1.32%
Change (1 day)
237.03%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.78. In 2024 the company made an earnings per share (EPS) of -โ‚น102.37 a decrease over its 2023 EPS that were of -โ‚น14.35.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-95.14%
2024-โ‚น102.37613.33%
2023-โ‚น14.35-92.31%
2022-โ‚น186.56-42.14%
2021-โ‚น322.4136.44%
2020-โ‚น236.30-21.84%
2019-โ‚น302.32-24.58%
2018-โ‚น400.86675.93%
2017-โ‚น51.66-68.05%
2016-โ‚น161.68168.25%
2015-โ‚น60.27-55%
2014-โ‚น133.943400%
2013-โ‚น3.83-108.68%
2012โ‚น44.1024.49%
2011โ‚น35.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.33-2,720.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,700-56,550.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,385-29,060.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น655.34-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น340.33-7,214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น340.59-7,220.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น169.34 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA